222

MEDIAN DIAGNOSTICS

No trades
See on Supercharts
Market capitalization
‪28.72 B‬KRW
‪−1.37 B‬KRW
‪11.89 B‬KRW
‪272.47 K‬
Beta (1Y)
−0.37
Employees (FY)
81
Change (1Y)
0
Revenue / Employee (1Y)
‪112.70 K‬KRW
Net income / Employee (1Y)
‪−12.98 K‬KRW

About MEDIAN DIAGNOSTICS


CEO
Jin-Sik Oh
Headquarters
Chuncheon-si
Founded
1999
ISIN
KR7233250000
FIGI
BBG00GZS6249
Median Diagnostics Inc. engages in the manufacture and supply of in vitro diagnostic products for animal diseases and raw materials for human disease diagnosis. It operates through the following business divisions: Immunodiagnosis, Microbiological diagnosis, Molecular Diagnostics, Clinical chemistry tests, Blood test, and Urine test. The Immunodiagnosis division uses fluorescent labels, enzymes, and other chemical indicators to detect and quantify the analyte. The Microbiological diagnosis division includes identification of bacterial pathogens, virus culture and isolation, and antibiotic susceptibility testing. The Molecular Diagnostics division offers tests for unique nucleic acid sequences. The Clinical Chemistry tests division examines the health of companion animals. The Blood test division deals with the analysis of infections, inflammation, immunodeficiency, anemia, leukemia and other hematological disorders in animals. The Urine test division handles conditions including liver disease, kidney disease and dysfunction, diabetes, infections and other potential diseases. The company was founded on October 18, 1999 and is headquartered in Chuncheon-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 233250 is 18,000 KRW — it has increased by 2.80% in the past 24 hours. Watch MEDIAN DIAGNOSTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MEDIAN DIAGNOSTICS stocks are traded under the ticker 233250.
233250 stock has risen by 24.15% compared to the previous week, the month change is a 24.15% rise, over the last year MEDIAN DIAGNOSTICS has showed a 33.26% increase.
233250 reached its all-time high on Mar 19, 2021 with the price of 63,000 KRW, and its all-time low was 8,600 KRW and was reached on Jun 12, 2024. View more price dynamics on 233250 chart.
See other stocks reaching their highest and lowest prices.
233250 stock is 2.72% volatile and has beta coefficient of −0.37. Track MEDIAN DIAGNOSTICS stock price on the chart and check out the list of the most volatile stocks — is MEDIAN DIAGNOSTICS there?
Today MEDIAN DIAGNOSTICS has the market capitalization of ‪28.83 B‬, it has increased by 0.14% over the last week.
Yes, you can track MEDIAN DIAGNOSTICS financials in yearly and quarterly reports right on TradingView.
No, 233250 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 81.00 employees. See our rating of the largest employees — is MEDIAN DIAGNOSTICS on this list?
Like other stocks, 233250 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIAN DIAGNOSTICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIAN DIAGNOSTICS technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIAN DIAGNOSTICS stock shows the buy signal. See more of MEDIAN DIAGNOSTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.